Concepedia

Tomoaki Fujisaki

TF

43

Publications

3K

Citations

24

H-Index

1995

Active since

Affiliations

Matsuyama Red Cross Hospital(Current)

Kyushu University

Japanese Red Cross Medical Center

National and Kapodistrian University of Athens

Fukuoka University

Tomoaki Fujisaki is an author at Matsuyama Red Cross Hospital specializing in medicine, immunology, and hematology.

Top concepts

Publications per year

1995–2025

43

Publications

43

Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma

María‐Victoria Mateos, Meletios Α. Dimopoulos, Michèle Cavo et al. · New England Journal of Medicine · 2017 · 949 citations · Full text

Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial

María‐Victoria Mateos, Michèle Cavo, Joan Bladé et al. · The Lancet · 2019 · 430 citations · Full text

, , +7

Transplantable hematopoietic stem cells in human fetal liver have a CD34+ side population (SP)phenotype

Naoyuki Uchida, Tomoaki Fujisaki, Allen Eaves et al. · Journal of Clinical Investigation · 2001 · 128 citations · Full text

Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma

Vânia Hungria, Paweł Robak, Marek Hus et al. · New England Journal of Medicine · 2024 · 127 citations

HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide after Busulfan-Containing Reduced-Intensity Conditioning

Junichi Sugita, Naomi Kawashima, Tomoaki Fujisaki et al. · Biology of Blood and Marrow Transplantation · 2015 · 108 citations

Rows per page

1–5 of 43